Literature DB >> 30139738

"Z4" Complex Member Fusions in NUT Carcinoma: Implications for a Novel Oncogenic Mechanism.

Hitoshi Shiota1, Janine E Elya1, Artyom A Alekseyenko2,3, Pauline M Chou4, Shelby A Gorman5, Olena Barbash5, Kelly Becht1, Kristina Danga1, Mitzi I Kuroda2,3, Valentina Nardi6, Christopher A French7.   

Abstract

Nuclear protein in testis (NUT) carcinoma (NC) is a rare, distinctly aggressive subtype of squamous carcinoma defined by the presence of NUT-fusion oncogenes resulting from chromosomal translocation. In most cases, the NUT gene (NUTM1) is fused to bromodomain containing 4 (BRD4) forming the BRD4-NUT oncogene. Here, a novel fusion partner to NUT was discovered using next-generation sequencing and FISH from a young patient with an undifferentiated malignant round cell tumor. Interestingly, the NUT fusion identified involved ZNF592, a zinc finger containing protein, which was previously identified as a component of the BRD4-NUT complex. In BRD4-NUT-expressing NC cells, wild-type ZNF592 and other associated "Z4" complex proteins, including ZNF532 and ZMYND8, colocalize with BRD4-NUT in characteristic nuclear foci. Furthermore, ectopic expression of BRD4-NUT in a non-NC cell line induces sequestration of Z4 factors to BRD4-NUT foci. Finally, the data demonstrate the specific dependency of NC cells on Z4 modules, ZNF532 and ZNF592. IMPLICATIONS: This study establishes the oncogenic role of Z4 factors in NC, offering potential new targeted therapeutic strategies in this incurable cancer.Visual Overview: http://mcr.aacrjournals.org/content/molcanres/16/12/1826/F1.large.jpg. ©2018 American Association for Cancer Research.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 30139738      PMCID: PMC6279489          DOI: 10.1158/1541-7786.MCR-18-0474

Source DB:  PubMed          Journal:  Mol Cancer Res        ISSN: 1541-7786            Impact factor:   5.852


  26 in total

1.  Oncogenesis by sequestration of CBP/p300 in transcriptionally inactive hyperacetylated chromatin domains.

Authors:  Nicolas Reynoird; Brian E Schwartz; Manuela Delvecchio; Karin Sadoul; David Meyers; Chandrani Mukherjee; Cécile Caron; Hiroshi Kimura; Sophie Rousseaux; Philip A Cole; Daniel Panne; Christopher A French; Saadi Khochbin
Journal:  EMBO J       Date:  2010-07-30       Impact factor: 11.598

Review 2.  The super elongation complex (SEC) family in transcriptional control.

Authors:  Zhuojuan Luo; Chengqi Lin; Ali Shilatifard
Journal:  Nat Rev Mol Cell Biol       Date:  2012-08-16       Impact factor: 94.444

3.  Suppression of Enhancer Overactivation by a RACK7-Histone Demethylase Complex.

Authors:  Hongjie Shen; Wenqi Xu; Rui Guo; Bowen Rong; Lei Gu; Zhentian Wang; Chenxi He; Lijuan Zheng; Xin Hu; Zhen Hu; Zhi-Ming Shao; Pengyuan Yang; Feizhen Wu; Yujiang Geno Shi; Yang Shi; Fei Lan
Journal:  Cell       Date:  2016-04-07       Impact factor: 41.582

4.  The Brd4 extraterminal domain confers transcription activation independent of pTEFb by recruiting multiple proteins, including NSD3.

Authors:  Shaila Rahman; Mathew E Sowa; Matthias Ottinger; Jennifer A Smith; Yang Shi; J Wade Harper; Peter M Howley
Journal:  Mol Cell Biol       Date:  2011-05-09       Impact factor: 4.272

5.  Midline carcinoma of children and young adults with NUT rearrangement.

Authors:  Christopher A French; Jeffery L Kutok; William C Faquin; Jeffrey A Toretsky; Cristina R Antonescu; Constance A Griffin; Vania Nose; Sara O Vargas; Mary Moschovi; Fotini Tzortzatou-Stathopoulou; Isao Miyoshi; Antonio R Perez-Atayde; Jon C Aster; Jonathan A Fletcher
Journal:  J Clin Oncol       Date:  2004-10-15       Impact factor: 44.544

6.  Intrathoracic carcinoma in an 11-year-old girl showing a translocation t(15;19).

Authors:  U R Kees; M T Mulcahy; M L Willoughby
Journal:  Am J Pediatr Hematol Oncol       Date:  1991

7.  BRD4-NUT fusion oncogene: a novel mechanism in aggressive carcinoma.

Authors:  Christopher A French; Isao Miyoshi; Ichiro Kubonishi; Holcombe E Grier; Antonio R Perez-Atayde; Jonathan A Fletcher
Journal:  Cancer Res       Date:  2003-01-15       Impact factor: 12.701

Review 8.  Translocation (11;15;19): a highly specific chromosome rearrangement associated with poorly differentiated thymic carcinoma in young patients.

Authors:  Jeffrey A Toretsky; James Jenson; Chen-Chih Sun; Allen E Eskenazi; Andrew Campbell; Stephen P Hunger; Aimee Caires; Christopher Frantz; J Laurance Hill; Judith Stamberg
Journal:  Am J Clin Oncol       Date:  2003-06       Impact factor: 2.339

9.  BRD-NUT oncoproteins: a family of closely related nuclear proteins that block epithelial differentiation and maintain the growth of carcinoma cells.

Authors:  C A French; C L Ramirez; J Kolmakova; T T Hickman; M J Cameron; M E Thyne; J L Kutok; J A Toretsky; A K Tadavarthy; U R Kees; J A Fletcher; J C Aster
Journal:  Oncogene       Date:  2007-10-15       Impact factor: 9.867

10.  The oncogenic BRD4-NUT chromatin regulator drives aberrant transcription within large topological domains.

Authors:  Artyom A Alekseyenko; Erica M Walsh; Xin Wang; Adlai R Grayson; Peter T Hsi; Peter V Kharchenko; Mitzi I Kuroda; Christopher A French
Journal:  Genes Dev       Date:  2015-07-15       Impact factor: 11.361

View more
  13 in total

1.  Recurrent chromosomal translocations in sarcomas create a megacomplex that mislocalizes NuA4/TIP60 to Polycomb target loci.

Authors:  Nikita Avvakumov; Marie-Eve Lalonde; Nader Alerasool; Charles Joly-Beauparlant; Karine Jacquet; Amel Mameri; Deepthi Sudarshan; Jean-Philippe Lambert; Justine Rousseau; Catherine Lachance; Eric Paquet; Lara Herrmann; Samarth Thonta Setty; Jeremy Loehr; Marcus Q Bernardini; Marjan Rouzbahman; Anne-Claude Gingras; Benoit Coulombe; Arnaud Droit; Mikko Taipale; Yannick Doyon; Jacques Côté
Journal:  Genes Dev       Date:  2022-06-16       Impact factor: 12.890

Review 2.  NUT Carcinoma of the Submandibular Gland: A Case at This Uncommon Site with Review of the Literature.

Authors:  Vanessa Moreno; Christopher A French; Tianhua Guo; Hui Zhu; Songling Zhang; Darryl Duncan; Ron J Karni; Angel I Blanco; Syed H Jafri; Karan Saluja
Journal:  Head Neck Pathol       Date:  2021-12-14

Review 3.  Update from the 5th Edition of the World Health Organization Classification of Head and Neck Tumors: Nasal Cavity, Paranasal Sinuses and Skull Base.

Authors:  Lester D R Thompson; Justin A Bishop
Journal:  Head Neck Pathol       Date:  2022-03-21

4.  Report of the First International Symposium on NUT Carcinoma.

Authors:  Christopher A French; Michael L Cheng; Glenn J Hanna; Steven G DuBois; Nicole G Chau; Christine L Hann; Simone Storck; Ravi Salgia; Matteo Trucco; Jennifer Tseng; Anastasios Stathis; Richard Piekarz; Ulrich M Lauer; Christophe Massard; Kelly Bennett; Shodeinde Coker; Ulrike Tontsch-Grunt; Martin L Sos; Sida Liao; Catherine J Wu; Kornelia Polyak; Sarina A Piha-Paul; Geoffrey I Shapiro
Journal:  Clin Cancer Res       Date:  2022-06-13       Impact factor: 13.801

Review 5.  An Overview of Molecular Mechanism, Clinicopathological Factors, and Treatment in NUT Carcinoma.

Authors:  Qian W Huang; Li J He; Shuang Zheng; Tao Liu; Bei N Peng
Journal:  Biomed Res Int       Date:  2019-11-11       Impact factor: 3.411

Review 6.  Supercharging BRD4 with NUT in carcinoma.

Authors:  Kyle P Eagen; Christopher A French
Journal:  Oncogene       Date:  2021-01-15       Impact factor: 9.867

7.  Primary Thyroid NUT Carcinoma With High PD-L1 Expression and Novel Massive IGKV Gene Fusions: A Case Report With Treatment Implications and Literature Review.

Authors:  Juan Zhou; Miao Duan; Qiong Jiao; Chunyan Chen; Aiyan Xing; Peng Su; Juan Tang; Hui Zhang; Zhiyan Liu
Journal:  Front Oncol       Date:  2022-01-19       Impact factor: 6.244

8.  Chemical Screen Identifies Diverse and Novel Histone Deacetylase Inhibitors as Repressors of NUT Function: Implications for NUT Carcinoma Pathogenesis and Treatment.

Authors:  Hitoshi Shiota; Artyom A Alekseyenko; Zhipeng A Wang; Ivona Filic; Tatiana M Knox; Nhi M Luong; Yeying Huang; David A Scott; Kristen L Jones; Prafulla C Gokhale; Madeleine E Lemieux; Philip A Cole; Mitzi I Kuroda; Christopher A French
Journal:  Mol Cancer Res       Date:  2021-07-20       Impact factor: 5.852

9.  Misleading Germ Cell Phenotype in Pulmonary NUT Carcinoma Harboring the ZNF532-NUTM1 Fusion.

Authors:  Abbas Agaimy; Florian Haller; André Renner; Jost Niedermeyer; Arndt Hartmann; Christopher A French
Journal:  Am J Surg Pathol       Date:  2022-02-01       Impact factor: 6.394

10.  Clinicopathological Analysis of Five Cases of NUT Midline Carcinoma, including One with the Gingiva.

Authors:  Luting Zhou; Xiang Yong; Jun Zhou; Jiankun Xu; Chaofu Wang
Journal:  Biomed Res Int       Date:  2020-02-13       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.